EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS1 holder
Total Value
$16.68M
Total Shares
733.4K
Net Share Change
-198.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$16.68M733.4K shares
TRIM-198.0K(-21.3%)